Evidence map›Paper›PMID 24872193›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Tetherin promotes the innate and adaptive cell-mediated immune response against retrovirus infection in vivo.

Sam X Li, Bradley S Barrett, Karl J Heilman, Ronald J Messer, Rachel A Liberatore, Paul D Bieniasz, George Kassiotis, Kim J Hasenkrug, Mario L Santiago

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Sam X LiDepartment of Medicine, University of Colorado, Denver, Aurora, CO 80045; Department of Microbiology, University of Colorado, Denver, Aurora, CO 80045;
Bradley S BarrettDepartment of Medicine, University of Colorado, Denver, Aurora, CO 80045;
Karl J HeilmanDepartment of Medicine, University of Colorado, Denver, Aurora, CO 80045;
Ronald J MesserRocky Mountain Laboratories, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840;
Rachel A LiberatoreHoward Hughes Medical Institute, Aaron Diamond AIDS Research Center, Rockefeller University, New York, NY 10016;
Paul D BieniaszHoward Hughes Medical Institute, Aaron Diamond AIDS Research Center, Rockefeller University, New York, NY 10016;
George KassiotisDivision of Immunoregulation, Medical Research Council National Institute for Medical Research, London NW7 1AA, United Kingdom; and.
Kim J HasenkrugRocky Mountain Laboratories, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840;
Mario L SantiagoDepartment of Medicine, University of Colorado, Denver, Aurora, CO 80045; Department of Microbiology, University of Colorado, Denver, Aurora, CO 80045; Department of Immunology, University of Colorado, Denver, Aurora, CO 80045 mario.santiago@ucdenver.edu.
University of Colorado Denver · USAaron Diamond AIDS Research Center · USGeneral Medical Council · GBHoward Hughes Medical Institute · USNational Institute of Allergy and Infectious Diseases · USNational Institutes of Health · US

Funding

Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Immunology And Pathology Of Acute Murine Leukemia Virus InfectionsZIAAI000753 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI HASENKRUG, KIM · 2009 to 2022
$8.1M
RNA Protein interactions in HIV-1 replicationR01AI050111 · NIAID · ROCKEFELLER UNIVERSITY · PI BIENIASZ, PAUL D. · 2001 to 2021
$7.9M
Immunology and Pathology of Chronic Murine Leukemia Virus InfectionsZIAAI001100 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI HASENKRUG, KIM · 2009 to 2015
$3.1M
Innate Restriction Factor Modulation of Retrovirus-specific Humoral ImmunityR01AI090795 · NIAID · UNIVERSITY OF COLORADO DENVER · PI SANTIAGO, MARIO LUIS · 2010 to 2013
$2.8M
Molecular Pathogenesis of Infectious DiseasesT32AI052066 · NIAID · UNIVERSITY OF COLORADO DENVER · PI VAN DYK, LINDA F. · 2002 to 2022
$2.3M
Colorado Clinical and Translational Sciences InstituteTL1TR001081 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$1.3M
Immunological impact of Tetherin retrovirus restrictionR21AI112418 · NIAID · UNIVERSITY OF COLORADO DENVER · PI SANTIAGO, MARIO LUIS · 2014 to 2015
$427k
Colorado Clinical and Translational Science Institute (TL1)TL1TR000155 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2012 to 2013
$294k
Howard Hughes Medical InstituteMedical Research Council MC_U117581330NCATS NIH HHS TL1 TR001081NCATS NIH HHS UL1 TR001082NIAID NIH HHS R01 AI050111NIAID NIH HHS R01 AI090795NIAID NIH HHS R21 AI112418NIAID NIH HHS T32 AI052066
6 · The paper itself

Abstract

Tetherin/BST-2 is a host restriction factor that could directly inhibit retroviral particle release by tethering nascent virions to the plasma membrane. However, the immunological impact of Tetherin during retrovirus infection remains unknown. We now show that Tetherin influences antiretroviral cell-mediated immune responses. In contrast to the direct antiviral effects of Tetherin, which are dependent on cell surface expression, the immunomodulatory effects are linked to the endocytosis of the molecule. Mice encoding endocytosis-competent C57BL/6 Tetherin exhibited lower viremia and pathology at 7 d postinfection with Friend retrovirus (FV) compared with mice encoding endocytosis-defective NZW/LacJ Tetherin. Notably, antiretroviral protection correlated with stronger NK cell responses. In addition, Friend retrovirus infection levels were significantly lower in wild-type C57BL/6 mice than in Tetherin knockout mice at 2 wk postinfection, and antiretroviral protection correlated with stronger NK cell and virus-specific CD8+ T cell responses. The results demonstrate that Tetherin acts as a modulator of the cell-mediated immune response against retrovirus infection in vivo.

Indexed as

Immunity, CellularAnimalsAntigens, CDBone Marrow Stromal Antigen 2CD8-Positive T-LymphocytesFriend murine leukemia virusKiller Cells, NaturalMembrane GlycoproteinsMiceMice, KnockoutRetroviridae InfectionsTime FactorsTumor Virus InfectionsViremiaAntigens, CDBone Marrow Stromal Antigen 2BST2 protein, mouseMembrane Glycoproteins

Identifiers

PMID24872193
PMCPMC4163935
OpenAlexW1907955033

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.